Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.

MLA

Anne Fleissig, et al. “Post-Operative Arm Morbidity and Quality of Life. Results of the ALMANAC Randomised Trial Comparing Sentinel Node Biopsy with Standard Axillary Treatment in the Management of Patients with Early Breast Cancer.” Breast Cancer Research & Treatment, vol. 95, no. 3, Feb. 2006, pp. 279–93. EBSCOhost, https://doi.org/10.1007/s10549-005-9025-7.

APA

Anne Fleissig, Lesley Fallowfield, Carolyn Langridge, Leigh Johnson, Robert Newcombe, J. Dixon, Mark Kissin, & Robert Mansel. (2006). Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Research & Treatment, 95(3), 279–293. https://doi.org/10.1007/s10549-005-9025-7

Chicago

Anne Fleissig, Lesley Fallowfield, Carolyn Langridge, Leigh Johnson, Robert Newcombe, J. Dixon, Mark Kissin, and Robert Mansel. 2006. “Post-Operative Arm Morbidity and Quality of Life. Results of the ALMANAC Randomised Trial Comparing Sentinel Node Biopsy with Standard Axillary Treatment in the Management of Patients with Early Breast Cancer.” Breast Cancer Research & Treatment 95 (3): 279–93. doi:10.1007/s10549-005-9025-7.